Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

954
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
954
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Leisure screen time, cardiometabolic pathways, and frailty: A two-step Mendelian randomization analysis.

Medicine·2026
Same author

Fast reconstruction of scalar and vector polymorphic beams through strong scattering media.

Optics express·2026
Same author

Neuromodulatory effects of voluntary-motor-effort-driven wrist-hand robot in sensorimotor dynamics after stroke.

Journal of neuroengineering and rehabilitation·2026
Same author

Atraric acid alleviates high-fat diet-induced cardiac injury via eEF2K.

The Journal of nutritional biochemistry·2026
Same author

Deviation analysis of guided fiber post removal using an assembled sleeveless guide system: A case series.

The Journal of prosthetic dentistry·2026
Same author

Underrecognized triploidy and genome-wide uniparental disomy in human blastocysts revealed by a concurrent preimplantation genetic testing approach.

Human reproduction open·2026

相关实验视频

Updated: Jan 12, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K

通过图形表示学习和基于知识的规范化来提高药物向相互作用预测.

Qihuan Yao1, Zhen Chen2, Ye Cao3

  • 1Department of Traditional Chinese Medicine, Kongjiang Hospital, Shanghai, China.

Frontiers in bioinformatics
|November 6, 2025
PubMed
概括
此摘要是机器生成的。

这项研究引入了一种新的深度学习框架,用于预测药物向相互作用 (DTI). 该模型将图形神经网络与生物知识相结合,大大提高了药物发现的预测准确性和可解释性.

关键词:
系统药理学 系统药理学计算机化药物查是指计算机化药物查.发现药物的发现.药物目标预测的预测代表性学习学习学习

更多相关视频

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K

相关实验视频

Last Updated: Jan 12, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

1.3K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

2.1K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K

科学领域:

  • 计算生物学 计算生物学
  • 药物发现 药物发现 药物发现
  • 生物信息学是一种生物信息学.

背景情况:

  • 准确预测药物向相互作用 (DTI) 对药物发现和重新定位至关重要.
  • 现有的深度学习方法难以捕捉复杂的药物目标关系,并有效地整合生物知识.

研究的目的:

  • 利用图形神经网络和知识集成,开发一个新的DTI预测框架.
  • 提高DTI预测模型的准确性和可解释性.

主要方法:

  • 一个定制的基于图形的消息传递方案来学习分子结构和蛋白质序列的表示.
  • 基于知识的规范化策略,以整合来自生物医学本体和数据库的领域知识.
  • 将图形神经网络 (GNN) 与用于DTI预测的知识集成相集成.

主要成果:

  • 在基准数据集上实现了平均AUC0.98和平均AUPR0.89,超过了最先进的方法.
  • 通过可视化学习的注意力权重,识别出突出的分子子结构和蛋白质动机,证明可解释性.
  • 对FDA批准的药物预测的新型DTI具有高的实验确认率.

结论:

  • 拟议的框架为DTI预测提供了一个强大而可解释的解决方案.
  • 这种方法有可能显著加快新药候选药物和治疗点的识别.
  • 该模型整合生物知识的能力提高了其在药物发现中的实际实用性.